Maze Therapeutics, Inc. Common Stock (MAZE) valuation · $525.3M cap
Maze Therapeutics, Inc. Common Stock (MAZE) $525.3M cap.
| Metric | Value |
|---|---|
| Market cap | $525.3M |
| Revenue | $20.0M |
| P/S | 26.3 |
MAZE valuation FAQ
What is MAZE's market cap?
Maze Therapeutics, Inc. Common Stock (MAZE) market cap is $525.3M on the latest cached fundamentals snapshot.
What is MAZE's latest revenue?
Latest cached Maze Therapeutics, Inc. Common Stock (MAZE) revenue was $20.0M. Statements: https://lician.com/financials/maze
What is MAZE's price-to-sales ratio?
Maze Therapeutics, Inc. Common Stock (MAZE) price-to-sales (P/S) is 26.3, cached market cap $525.3M divided by revenue $20.0M.
How many MAZE valuation scalars are listed on this page?
This page lists 3 cached valuation scalars for Maze Therapeutics, Inc. Common Stock (MAZE): Market cap, Revenue, and P/S.
Where is MAZE valuation listed?
Cached valuation multiples for Maze Therapeutics, Inc. Common Stock (MAZE) are listed at https://lician.com/valuation/maze.
Not investment advice. Cached rows, not a live tape.